Date Filed | Type | Description |
01/04/2022 |
SC 13G
| Domain Partners VIII, L.P. reports a 8.6% stake in SERA PROGNOSTICS, INC. |
01/21/2021 |
SC 13G/A
| Domain Partners VIII, L.P. reports a 0.9% stake in aTyr Pharma, Inc. |
01/20/2021 |
SC 13G/A
| Domain Partners VIII, L.P. reports a 2.5% stake in Syndax Pharmaceuticals, Inc. |
01/20/2021 |
SC 13G/A
| Domain Partners VIII, L.P. reports a 2.9% stake in Milestone Pharmaceuticals Inc. |
01/20/2021 |
SC 13G/A
| Domain Partners VIII, L.P. reports a 0% stake in Bionano Genomics, Inc. |
01/10/2020 |
SC 13G/A
| Domain Partners VIII, L.P. has filed a Schedule 13D for Veracyte, Inc. |
01/09/2020 |
SC 13G
| Domain Partners VIII, L.P. reports a 7.6% stake in Milestone Pharmaceuticals Inc. |
05/13/2019 |
SC 13D
| Domain Partners VIII, L.P. reports a 52.3% stake in Adynxx, Inc. |
01/11/2019 |
SC 13G
| Domain Partners VIII, L.P. reports a 9.5% stake in Bionano Genomics, Inc. |
01/11/2019 |
SC 13G/A
| Domain Partners VIII, L.P. reports a 5.6% stake in Veracyte, Inc. |
11/05/2018 |
SC 13D/A
| Domain Partners VIII, L.P. reports a 4.7% stake in Dicerna Pharmaceuticals, Inc. |
01/08/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
12/20/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/14/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
04/20/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
01/09/2017 |
SC 13G
| Domain Partners VIII, L.P. reports a 9.6% stake in Syndax Pharmaceuticals, Inc. |
07/25/2013 |
SC 13D
| Domain Partners VIII, L.P. reports a 16.7% stake in Ocera Therapeutics, Inc. |
08/02/2012 |
SC 13D
| Durata Therapeutics, Inc. reports a 17.4% stake in Durata Therapeutics, Inc. |
06/15/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
08/30/2010 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |